APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,889,286 | -60.2% | 102,242 | -4.6% | 0.05% | -46.5% |
| Q2 2023 | $9,759,999 | +6.8% | 107,135 | -22.7% | 0.09% | -3.4% |
| Q1 2023 | $9,142,188 | +11.2% | 138,602 | -12.8% | 0.09% | +3.5% |
| Q4 2022 | $8,218,012 | -99.9% | 158,925 | -5.9% | 0.09% | -31.7% |
| Q3 2022 | $11,540,719,000 | +142044.6% | 168,971 | -5.9% | 0.13% | +57.5% |
| Q2 2022 | $8,119,000 | -15.6% | 179,550 | -5.1% | 0.08% | +8.1% |
| Q1 2022 | $9,614,000 | -39.7% | 189,223 | -43.8% | 0.07% | +25.4% |
| Q4 2021 | $15,932,000 | +2765.5% | 336,978 | +1896.0% | 0.06% | +883.3% |
| Q3 2021 | $556,000 | -61.1% | 16,883 | -25.4% | 0.01% | -62.5% |
| Q2 2021 | $1,430,000 | +54.4% | 22,625 | +4.9% | 0.02% | +33.3% |
| Q1 2021 | $926,000 | – | 21,578 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |